Afmgcyp51atr34tr46mtbalnaaprobe

This test is a laboratory analysis performed on a small sample from your body to give your healthcare team important information about your health. It can help detect a medical condition, confirm a diagnosis, or check how well a treatment is working over time.

The Aspergillus CYP51A Resistance Mutation Test is a molecular test that looks for specific genetic changes (called TR34 and TR46 mutations) in the CYP51A gene of Aspergillus fumigatus fungus. These mutations can make the fungus resistant to certain antifungal medications called azoles (such as voriconazole, posaconazole, and itraconazole).

The sample is usually collected at a clinic, hospital, or laboratory. Depending on what your doctor has ordered, this may involve drawing a small amount of blood from a vein in your arm, collecting a urine sample, or taking a swab from the affected area. The procedure is typically quick, and you can usually return to your normal activities right away.

For this test, a sample of bronchoalveolar lavage (BAL) fluid is collected. During a bronchoscopy, salt water is flushed into a specific area of the lung and then collected back. This fluid contains cells and material from the airways and lungs, which can be tested for the presence of Aspergillus and its genetic mutations.

This test is important because it provides objective information that guides your care. It can help identify health problems early, before symptoms appear, and allows your provider to make informed decisions about diagnosis, treatment, and follow-up monitoring.

This test is important because azole-resistant Aspergillus infections are becoming more common worldwide. When a patient has an invasive Aspergillus infection that does not improve with standard antifungal treatment, doctors need to know if the fungus has these resistance mutations. This information helps them select alternative antifungal medications that will be more effective.

Your results will be compared with a reference range, which is the expected range for healthy individuals. A value outside this range does not always mean something is wrong, so it is best to review your results with your healthcare provider, who can explain what they mean in the context of your overall health.

If the test detects TR34 or TR46 mutations, it means the Aspergillus strain is likely resistant to azole antifungal drugs. Your doctor will then choose a different class of antifungal medication for treatment. If no mutations are found, standard azole medications may still be effective, though your doctor will consider the complete clinical picture.